Literature DB >> 22975426

The role of osmotic polysorbitol-based transporter in RNAi silencing via caveolae-mediated endocytosis and COX-2 expression.

Mohammad Ariful Islam1, Ji-Young Shin, Jannatul Firdous, Tae-Eun Park, Yun-Jaie Choi, Myung-Haing Cho, Cheol-Heui Yun, Chong-Su Cho.   

Abstract

Polymeric diversity allows us to design gene carriers as an alternative to viral vectors, control cellular uptake, target intracellular molecules, and improve transfection and silencing capacity. Recently, we developed a polysorbitol-based osmotically active transporter (PSOAT), which exhibits several interesting mechanisms to accelerate gene delivery into cells. Herein, we report the efficacy of using the PSOAT system for small interfering RNA (siRNA) delivery and its specific mechanism for cellular uptake to accelerate targeted gene silencing. We found that PSOAT functioned via a caveolae-mediated uptake mechanism due to hyperosmotic activity of the transporter. Moreover, this selective caveolae-mediated endocytosis of the polyplexes (PSOAT/siRNA) was regulated coincidently with the expression of caveolin (Cav)-1 and cyclooxygenase (COX)-2. Interestingly, COX-2 expression decreased dramatically over time due to degradation by the constant expression of Cav-1, as confirmed by high COX-2 expression after the inhibition of Cav-1, suggesting that PSOAT-mediated induction of Cav-1 directly influenced the selective caveolae-mediated endocytosis of the polyplexes. Furthermore, COX-2 expression was involved in the initial phase for rapid caveolae endocytic uptake of the particles synergistically with Cav-1, resulting in accelerated PSOAT-mediated target gene silencing.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975426     DOI: 10.1016/j.biomaterials.2012.08.049

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

1.  Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability.

Authors:  Wei He; Michael J Bennett; Leopoldo Luistro; Daisy Carvajal; Thomas Nevins; Melissa Smith; Gaurav Tyagi; James Cai; Xin Wei; Tai-An Lin; David C Heimbrook; Kathryn Packman; John F Boylan
Journal:  Mol Ther       Date:  2013-09-03       Impact factor: 11.454

2.  Potential of caveolae in the therapy of cardiovascular and neurological diseases.

Authors:  Gemma Navarro; Dasiel O Borroto-Escuela; Kjell Fuxe; Rafael Franco
Journal:  Front Physiol       Date:  2014-09-30       Impact factor: 4.566

3.  Vimentin Targeted Nano-gene Carrier for Treatment of Renal Diseases.

Authors:  Ansuja Pulickal Mathew; Saji Uthaman; Eun Hui Bae; Jae Young Lee; In-Kyu Park
Journal:  J Korean Med Sci       Date:  2021-12-20       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.